Zim Laboratories Share Price

Name: Zim Laboratories
Brand: Zim Laboratories

Pharmaceuticals Small Cap

₹106.₂₀ +1.15 (1.09%)

05 Nov, 2024 17:28

Start SIP in ZIMLAB

Start SIP

Performance

Low
₹105

High
₹108

52 Week Low
₹90

52 Week High
₹131

Open Price₹105
Previous Close₹105
Volume40,839

Investment Returns

Over 1 Month -1.21%
Over 3 Month -6.76%
Over 6 Month -10.83%
Over 1 Year -14.49%

Smart Investing Starts Here Start SIP with Zim Laboratories for Steady Growth!

Invest Now

Zim Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

P/E Ratio
28.9

PEG Ratio
-3.5

Market Cap Cr
518

P/B Ratio
2.2

Average True Range
3.99

Dividend Yield
0

MACD Signal
-1.36

RSI
44.7

MFI
50.66

Standalone Consolidated

Indicator	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Net Sales/Income from operations	82.00	117.39	95.82	85.26	67.01
Total Income From Operations	82.00	117.39	95.82	85.26	67.01
P/L Before Interest, Excpt. Items & Tax	3.94	13.08	8.71	6.67	1.51
P/L Before Exceptional Items & Tax	1.08	10.80	7.01	5.45	-0.22
P/L After Tax from Ordinary Activities	0.76	7.89	4.83	4.18	-0.14
Net Profit/Loss For the Period	0.76	7.89	4.83	4.18	-0.14

Indicator	Mar 24	Mar 23
Revenue From Operations [Gross]	353.56	386.73
Revenue From Operations [Net]	353.56	386.73
Total Operating Revenues	365.47	396.53
Total Revenue	370.16	402.96
Total Expenses	347.12	367.04
Profit/Loss Before Tax	23.04	35.92
Profit/Loss For The Period	16.76	25.01

Indicator	Mar 24	Mar 23
Net CashFlow - Operating Activity	11.47	35.23
Net Cash Used In Investing Activity	-71.94	-35.21
Net Cash Used in Finance Activity	59.53	0.55
Net Inc/Dec In Cash And Equivalent	-0.94	0.57
Cash And Equivalent End Of Year	0.17	1.11

Indicator	Mar 24	Mar 23
Total Share Capital	48.73	48.73
Total Non-Current Liabilities	48.65	30.45
Total Current Liabilities	161.90	110.24
Total Capital And Liabilities	442.50	334.87
Total Non-Current Assets	224.79	156.23
Total Current Assets	217.71	178.64
Total Assets	442.50	334.87

Indicator	2024	2023
EBIT Margin (%)	8.19	10.46
Return On Capital Employed (%)	10.67	18.47
Return On Equity (%)	7.22	12.87
Long Term Debt To Equity (%)	15.34	12.68
Book Value/Share (INR)	47.60	39.85

Indicator	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Net Sales/Income from operations	81.82	117.86	96.29	85.83	67.44
Total Income From Operations	81.82	117.86	96.29	85.83	67.44
P/L Before Interest, Excpt. Items & Tax	4.09	13.28	8.71	6.66	1.92
P/L Before Exceptional Items & Tax	1.23	11.00	7.01	5.44	0.19
P/L After Tax from Ordinary Activities	0.90	8.09	4.78	4.15	0.23
Net Profit/Loss For the Period	0.90	8.09	4.78	4.15	0.23

Indicator	Mar 24	Mar 23
Revenue From Operations [Gross]	355.51	388.73
Revenue From Operations [Net]	355.51	388.73
Total Operating Revenues	367.42	398.53
Total Revenue	372.61	404.94
Total Expenses	348.97	369.59
Profit/Loss Before Tax	23.64	35.36
Profit/Loss For The Period	17.25	24.43

Indicator	Mar 24	Mar 23
Net CashFlow - Operating Activity	16.28	37.52
Net Cash Used In Investing Activity	-73.01	-36.20
Net Cash Used in Finance Activity	59.53	0.55
Net Inc/Dec In Cash And Equivalent	3.18	3.00
Cash And Equivalent End Of Year	9.60	6.42

Indicator	Mar 24	Mar 23
Total Share Capital	48.73	48.73
Total Non-Current Liabilities	48.65	30.45
Total Current Liabilities	159.43	110.79
Total Capital And Liabilities	446.82	341.58
Total Non-Current Assets	219.17	150.63
Total Current Assets	227.65	190.95
Total Assets	446.82	341.58

Indicator	2024	2023
EBIT Margin (%)	8.31	10.27
Return On Capital Employed (%)	10.63	17.73
Return On Equity (%)	7.22	12.19
Long Term Debt To Equity (%)	14.91	12.29
Book Value/Share (INR)	49.00	41.12

Zim Laboratories Technicals

EMA & SMA

Current Price

₹106.₂₀

+ 1.15 (1.09%)

Bullish Moving Average 0

Bearish Moving Average 0

EMA SMA

20 Day
₹107.02

50 Day
₹108.95

100 Day
₹109.61

200 Day
₹109.41

Resistance and Support

105.32

R3 107.73
R2 107.02
R1 106.03

S1 104.33
S2 103.62
S3 102.63

Is Zim Laboratories Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Zim Laboratories has an operating revenue of Rs. 381.81 Cr. on a trailing 12-month basis. An annual revenue de-growth of -8% needs improvement, Pre-tax margin of 6% is okay, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 15%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 18% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 22 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 32 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Zim Laboratories Corporate Actions - Bonus, Splits, Dividends

Board
Bonus

Date	Purpose	Remarks
2024-08-03	Quarterly Results
2024-05-13	Audited Results
2024-01-29	Quarterly Results
2023-11-01	Quarterly Results
2023-08-14	Quarterly Results

Date	Purpose	Remarks
2022-12-22	Bonus	Rs.0.00 issue in the ratio of 2:1 of Rs. 10/-

Zim Laboratories F&O

Zim Laboratories Shareholding Pattern

Sep 24
Jun 24
Mar 24
Dec 23

Promoters
Foreign Portfolio Investors
Individual Investors
Others

Promoters

33.26%

Foreign Portfolio Investors

Individual Investors

45.48%

Others

21.26%

NSE Symbol
ZIMLAB

BSE Symbol
541400

Chairman & Managing Director
Dr. Anwar Daud

ISIN
INE518E01015

Start Investing in 5* minutes

+91

By proceeding, you agree to our T&Cs*

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

Zim Laboratories Share Price

₹106.₂₀ +1.15 (1.09%)

Performance

Investment Returns

Smart Investing Starts Here Start SIP with Zim Laboratories for Steady Growth!

Zim Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Zim Laboratories Financial

Zim Laboratories Technicals

EMA & SMA

Resistance and Support

Is Zim Laboratories Worth Buying?

Ratings

Zim Laboratories Corporate Actions - Bonus, Splits, Dividends

Zim Laboratories F&O

Zim Laboratories Shareholding Pattern

Zim Laboratories FAQs

What is Share Price of Zim Laboratories ?

What is the Market Cap of Zim Laboratories ?

What is the P/E ratio of Zim Laboratories ?

What is the PB ratio of Zim Laboratories ?

Start Investing in 5* minutes

Zim Laboratories Share Price

₹106.20 +1.15 (1.09%)

Performance

Investment Returns

Smart Investing Starts Here Start SIP with Zim Laboratories for Steady Growth!

Zim Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Zim Laboratories Financial

Zim Laboratories Technicals

EMA & SMA

Resistance and Support

Is Zim Laboratories Worth Buying?

Ratings

Zim Laboratories Corporate Actions - Bonus, Splits, Dividends

Zim Laboratories F&O

Zim Laboratories Shareholding Pattern

Zim Laboratories FAQs

What is Share Price of Zim Laboratories ?

What is the Market Cap of Zim Laboratories ?

What is the P/E ratio of Zim Laboratories ?

What is the PB ratio of Zim Laboratories ?

Start Investing in 5* minutes

₹106.₂₀ +1.15 (1.09%)